Micro Emerging Active

Barclays alza il prezzo obiettivo di Ionis a $106

New narrative with limited coverage — still forming.

Punteggio
0,3
Velocità
▲ 0,0
Articoli
3
Fonti
1

Sentiment Timeline

Event Timeline

Apr 02, 2026
Barclays Reaffirms Equal Weight Rating for uniQure (QURE) Neutral
Mar 31, 2026
Cantor Fitzgerald Cuts PT on Apellis Pharmaceuticals (APLS) to $31 From $35 … Bearish
Mar 26, 2026
Why Barclays Thinks Ionis Is Headed for a 45% Surge From $73 … Neutral

Cronologia

Prima apparizioneMar 26, 2026
Ultimo aggiornamentoMar 26, 2026